Inclisiran—New hope in the management of lipid disorders?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inclisiran—New hope in the management of lipid disorders?

Published:2020-01 Issue:1 Volume:14 Page:16-27
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Dyrbuś Krzysztof,Gąsior Mariusz,Penson Peter,Ray Kausik K.,Banach Maciej

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference61 articles.

1. Multi-centre National Population Health Examination Survey (WOBASZ II study): assumptions, methods, and implementation;Drygas;Kardiol Pol,2016

2. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2019

3. PoLA/CFPiP/PCS guidelines for the management of dyslipidaemias for family physicians 2016;Banach;Arch Med Sci,2017

4. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy;J Am Coll Cardiol,2019

5. 2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult;Anderson;Can J Cardiol,2016

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Idiosyncratic Drug-Induced Liver Injury in a Healthy Patient following PCSK9-Inhibitor Injection;Case Reports in Hepatology;2024-01-11

2. A systematic review and meta-analysis of tolerability, cardiac safety and efficacy of inclisiran for the therapy of hyperlipidemic patients;Expert Opinion on Drug Safety;2023-12-08

3. Antisense oligonucleotides: a novel Frontier in pharmacological strategy;Frontiers in Pharmacology;2023-11-17

4. High interindividual variability in LDL-cholesterol reductions after inclisiran administration in a real-world multicenter setting in Germany;Clinical Research in Cardiology;2023-07-09

5. Current and future options in cholesterol lowering treatments;European Journal of Internal Medicine;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3